The information highlighted (if any) are the most recent updates for this brand.
Tambocor is contra-indicated in cardiac failure, and in patients with a history of myocardial infarction who have either asymptomatic ventricular ectopics of asymptomatic non-sustained ventricular tachycardia. It is also contra-indicated in patients with long standing atrial fibrillation in whom there has been no attempt to convert to sinus rhythm, and in patients with heamodynamically significant valvular heart disease. Unless pacing rescue is available, Tambocor should not be given to patients with sinus node dysfunction, atrial conduction defects, second degree or greater atrioventricular block, bundle branch block or distal block.
Sign Out
